Physician profile
Joni Lu
NPI 1104110592
$4,082.21
in general payments reported to CMS, 2019-2025
22 companies · $1,265 in 2025
The $1,265 reported for 2025 was more than what 82% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $248 · 2020: $45.32 · 2021: $537 · 2022: $612 · 2023: $675 · 2024: $700 · 2025: $1,265.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,539 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,539.23 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sun Pharmaceutical Industries INC. | $976.08 | 2019-2025 | Cequa |
| Mallinckrodt Hospital Products INC. | $723.22 | 2021-2025 | Acthar |
| Alcon Vision LLC | $276.94 | 2021-2025 | Rocklatan, Hydrus Microstent, Acrysof Iq Vivity |
| Kala Pharmaceuticals, INC. | $243.98 | 2019-2022 | |
| Oyster Point Pharma, INC. | $227.38 | 2022-2025 | Tyrvaya |
| Harrow Eye, LLC | $199.05 | 2025 | Vevye |
| Bausch & Lomb Americas INC. | $174.59 | 2022-2025 | Vyzulta, Miebo, Xiidra |
| Dompe US, INC. | $165.54 | 2020-2025 | Oxervate |
| Sight Sciences, INC. | $155.54 | 2023-2025 | Omni Surgical System, Tearcare System |
| Abbvie INC. | $154.93 | 2022-2025 | |
| Tarsus Pharmaceuticals, INC. | $148.78 | 2025 | Xdemvy |
| Novartis Pharmaceuticals Corporation | $145.04 | 2019-2022 | |
| Amgen INC. | $99.27 | 2024-2025 | Tepezza |
| Aerie Pharmaceuticals, INC. | $80.54 | 2019-2021 | |
| Allergan, INC. | $74.18 | 2019-2021 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb, A Division of Bausch Health US, LLC | $69.54 | 2019-2021 | |
| Johnson & Johnson Surgical Vision, INC. | $42.84 | 2022-2023 | Tecnis Iol, Tecnis Simplicity, Tecnis Iol |
| Eyevance Pharmaceuticals LLC | $33.45 | 2021 | |
| Biotissue Holdings INC. | $32.70 | 2021 | |
| Thea Pharma INC. | $21.85 | 2023 | Iyuzeh |
| Shire North American Group INC | $19.52 | 2019 | |
| Rxsight INC | $17.25 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joni Lu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.